PureTech Health Number Of Shares Shorted vs. Price To Book

PRTC Stock  USD 22.56  0.20  0.89%   
Considering the key profitability indicators obtained from PureTech Health's historical financial statements, PureTech Health PLC may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in January. Profitability indicators assess PureTech Health's ability to earn profits and add value for shareholders. At present, PureTech Health's Sales General And Administrative To Revenue is projected to increase based on the last few years of reporting. The current year's Days Of Sales Outstanding is expected to grow to 341.14, whereas Price To Sales Ratio is forecasted to decline to 222.13. At present, PureTech Health's Income Tax Expense is projected to increase significantly based on the last few years of reporting. The current year's Net Interest Income is expected to grow to about 2.7 M, whereas Operating Income is forecasted to decline to (153.5 M).
For PureTech Health profitability analysis, we use financial ratios and fundamental drivers that measure the ability of PureTech Health to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well PureTech Health PLC utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between PureTech Health's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of PureTech Health PLC over time as well as its relative position and ranking within its peers.
  
Check out Your Equity Center.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PureTech Health. If investors know PureTech will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PureTech Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.615
Earnings Share
(3.00)
Revenue Per Share
0.02
Quarterly Revenue Growth
(0.91)
Return On Assets
(0.13)
The market value of PureTech Health PLC is measured differently than its book value, which is the value of PureTech that is recorded on the company's balance sheet. Investors also form their own opinion of PureTech Health's value that differs from its market value or its book value, called intrinsic value, which is PureTech Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PureTech Health's market value can be influenced by many factors that don't directly affect PureTech Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PureTech Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if PureTech Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PureTech Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

PureTech Health PLC Price To Book vs. Number Of Shares Shorted Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining PureTech Health's current stock value. Our valuation model uses many indicators to compare PureTech Health value to that of its competitors to determine the firm's financial worth.
PureTech Health PLC is rated below average in number of shares shorted category among its peers. It is rated below average in price to book category among its peers . The ratio of Number Of Shares Shorted to Price To Book for PureTech Health PLC is about  12,050 . The current year's Price To Book Ratio is expected to grow to 1.76. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the PureTech Health's earnings, one of the primary drivers of an investment's value.

PureTech Price To Book vs. Number Of Shares Shorted

Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.

PureTech Health

Shares Shorted

 = 

Shorted by Public

+

by Institutions

 = 
20.6 K
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

PureTech Health

P/B

 = 

MV Per Share

BV Per Share

 = 
1.71 X
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.

PureTech Price To Book Comparison

PureTech Health is currently under evaluation in price to book category among its peers.

PureTech Health Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in PureTech Health, profitability is also one of the essential criteria for including it into their portfolios because, without profit, PureTech Health will eventually generate negative long term returns. The profitability progress is the general direction of PureTech Health's change in net profit over the period of time. It can combine multiple indicators of PureTech Health, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income129.1 M135.6 M
Operating Income-146.2 M-153.5 M
Income Before Tax-36.1 M-34.3 M
Total Other Income Expense Net110.1 M96.7 M
Net Loss-65.7 M-62.4 M
Income Tax Expense30.5 M32.1 M
Net Interest Income2.5 M2.7 M
Interest Income16 M16.8 M
Net Loss-66.6 M-63.3 M
Net Loss-69.6 M-66.2 M
Change To Netincome-95.3 M-100 M
Net Loss(2.38)(2.26)
Income Quality 1.61  1.69 
Net Income Per E B T 1.82  1.91 

PureTech Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on PureTech Health. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of PureTech Health position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the PureTech Health's important profitability drivers and their relationship over time.

Use PureTech Health in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if PureTech Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PureTech Health will appreciate offsetting losses from the drop in the long position's value.

PureTech Health Pair Trading

PureTech Health PLC Pair Trading Analysis

The ability to find closely correlated positions to PureTech Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace PureTech Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back PureTech Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling PureTech Health PLC to buy it.
The correlation of PureTech Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as PureTech Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if PureTech Health PLC moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for PureTech Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your PureTech Health position

In addition to having PureTech Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Real Estate ETFs Thematic Idea Now

Real Estate ETFs
Real Estate ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Real Estate ETFs theme has 65 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Real Estate ETFs Theme or any other thematic opportunities.
View All  Next Launch
When determining whether PureTech Health PLC offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of PureTech Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Puretech Health Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Puretech Health Plc Stock:
Check out Your Equity Center.
You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
To fully project PureTech Health's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of PureTech Health PLC at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include PureTech Health's income statement, its balance sheet, and the statement of cash flows.
Potential PureTech Health investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although PureTech Health investors may work on each financial statement separately, they are all related. The changes in PureTech Health's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on PureTech Health's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.